World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 17 December 2019
Main ID:  IRCT2016092429960N1
Date of registration: 2016-12-01
Prospective Registration: No
Primary sponsor: Tehran University of Medical Sciences
Public title: Comparison of the therapeutic effect of topical sildenafil gel and oral sildenafil pill in patients with erectile dysfunction
Scientific title: Comparison of the therapeutic effect of topical sildenafil gel and oral sildenafil pill in patients with erectile dysfunction
Date of first enrolment: 2016-10-22
Target sample size: 90
Recruitment status: Complete
URL:  http://en.irct.ir/trial/23954
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: All patients will be randomized with a blocked randomization technique. The treatment group will be assigned with Excel software and use of Rand Function. Patients will be grouped into four-person groups. Physician and patients are not informed about treatment, Blinding description: In the present study, the physician and the drug provider will not be aware of the type of treatment and the group of patients. All patients will receive tablets and gels that have the same appearance and are not aware of the treatment group. Medications with labels A and B are indicated for final analysis and return of results.  
Phase:  3
Countries of recruitment
Iran (Islamic Republic of)
Contacts
Name: Farshad Sheibani   
Address:  Tehran University of Medical Sciences, Pour Sina alley, Keshavarz Blvd., Tehran 1417653761 Tehran Iran (Islamic Republic of)
Telephone: +98 21 8889 3974
Email: f-sheybaeem@razi.tums.ac.ir
Affiliation:  Tehran University of Medical Sciences
Name: Farshad sheibani   
Address:  Tehran University of Medical Sciences, Pour Sina alley, Keshavarz Blvd., Tehran 1417653761 Tehran Iran (Islamic Republic of)
Telephone: +98 21 8889 3974
Email: f-sheybaeem@razi.tums.ac.ir
Affiliation:  Tehran University of Medical Sciences
Key inclusion & exclusion criteria
Inclusion criteria: Age between 30 to 70 years
having erectile dysfunction

Exclusion criteria: Penile anatomic abnormalities
other sexual dysfunctions
spinal cord injuries
Acute myocardial infarction within last 6 months
Cerebrovascular accident
nitrate drug use
Peptic ulcer disease
Migrane
visual disturbances
Allergic rhinitis


Age minimum: 30 years
Age maximum: 70 years
Gender: Male
Health Condition(s) or Problem(s) studied
F52.2,N48.
Erectile dysfunction.
The principal problem in men is erectile dysfunction (difficulty in developing or maintaining an erection suitable for satisfactory intercourse),
Intervention(s)
Intervention 1: Oral sildenafil pill 50 mg one hour before sexual contact for one month in intervention group. Intervention 2: Topical sildenafil gel which applied half an hour before sexual contact on penis for one month in intervention group. Intervention 3: Placebo Pill and Placebo Gel before sexual contact for one month in control group.
Primary Outcome(s)
Dorsal penile artery RI. Timepoint: before intervention, two weeks after intervention. Method of measurement: Color doppler sonography of the penis.
Sexual satisfaction of patient. Timepoint: before intervention, one month after intervention. Method of measurement: International index of erectile function questionnaire (IIEF).
Dorsal penile artery PSV. Timepoint: before intervention, two weeks after intervention. Method of measurement: Color doppler sonography of the penis.
Dorsal penile vein EDV. Timepoint: before intervention, two weeks after intervention. Method of measurement: Color doppler sonography of the penis.
Erection quality. Timepoint: before intervention, one month after intervention. Method of measurement: regidity of the penis during sexual contact based on patient interview.
Erection time. Timepoint: before intervention, one month after intervention. Method of measurement: The stability of erection before orgasm or ejaculation based on patient interview.
Sexual satisfaction of patient's sexual partner. Timepoint: before intervention, one month after intervention. Method of measurement: sexual partner satisfaction questionnaire.
Secondary Outcome(s)
Complication. Timepoint: during study and one month after intervention. Method of measurement: based on patient interview.
Secondary ID(s)
Source(s) of Monetary Support
Tehran University of Medical Sciences
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
?Ethics committe of Tehran University of Medical Sciences
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history